AQST Aquestive Therapeutics, Inc.
$4.68
Aquestive Therapeutics, Inc. (AQST) Earnings News
Earnings press releases, previews and reviews for Aquestive Therapeutics, Inc. (AQST), newest first.
Tuesday
August 11, 2026
4:01 PM ET
Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Wednesday
July 29, 2026
7:00 AM ET
Aquestive Therapeutics to Report Second Quarter 2026 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET
Wednesday
May 13, 2026
4:01 PM ET
Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
Wednesday
May 6, 2026
7:00 AM ET
Aquestive Therapeutics to Report First Quarter 2026 Financial Results and Recent Business Highlights on May 13 and Host Conference Call on May 14 at 8:00 a.m. ET
Monday
March 30, 2026
7:00 AM ET
Aquestive Therapeutics Announces Completion of Type A Meeting with FDA for Anaphylm™ (dibutepinephrine) Sublingual Film